Corindus is committed to providing best-in-class educational resources and events to physicians, staff and our hospital partners. With this in mind, we developed a brand new website to support continuing education in the field of vascular robotics. We are very excited to announce the launch of RoboticPCI.com.
The CorPath® Vascular Robotic System is the first FDA cleared robotic platform that offers interventional cardiologists precise procedure and stent control during vascular interventions. Offering robotics gives patients access to innovative technologies coupled with robotic precision. In addition, the development of a comprehensive Vascular Robotic Program can improve safety to the physicians and staff who spend their lives devoted to caring for others.
In order to successfully implement a comprehensive Vascular Robotic Program, it is critical for bedside staff, which may include both fellows and allied health professionals, to be willing to learn new technologies and commit to investing the time and effort needed to master new skills. The Corindus team offers Advanced User Training (AUT) courses to continue educating cath lab staff to help build and advance their robotic skills with CorPath GRX. Our courses are a full day of hands-on learning held throughout the year, targeting Technologists, RCIS, RN, CVIT, CIT and others in the cath lab.
VIDEO: Left Trans-Radial Robotic PCI of Obtuse Marginal
Paul T. Campbell, MD
Carolinas HealthCare System NorthEast
Dr. Paul Campbell showcases the applicability of CorPath GRX in complex multi-vessel PCI via left radial access. See the benefits of guide catheter control in action and understand how robotics can enable increased utilization of left radial to benefit patients with previous CABG, right subclavian artery tortuosity and for patients that are right hand dominant.
Our last blog focused on the rising trend towards performing percutaneous coronary intervention (PCI) transradially, or catheterization via wrist access, in the United States. As medical professionals continue looking for ways to improve patient care, the adoption of transradial access (TRA) grows because of the well-documented patient benefits. There is significant evidence that TRA offers clinical benefits for patients, including fewer major bleeding and vascular complications, reduced incidence of other adverse events and faster discharge1.
For many years, percutaneous coronary intervention (PCI) was performed almost exclusively via transfemoral (groin) access. Over the years, there has been a significant trend towards transradial (wrist) access. Transradial access (TRA) is considered the standard in many parts of the world but in the United States, adoption has been slower. That said, the percentage of procedures that are performed radially in the US has increased steadily over the last decade, reaching approximately 30% in current practice.
The topic of radiation safety in the cath lab has been on the rise in recent years. In 2015 alone, there were 42 publications related to the occupational hazards of working with interventional fluoroscopy, an amount double that of the year prior. Some risks have been widely known for a while including radiation-induced cancer, cataracts, and orthopedic strain from heavy lead protective equipment. Others have been uncovered only more recently including accelerated vascular aging, cognitive impairment, hypertension, and left-sided brain tumors.
Earlier this month, the second annual San Diego Cardiovascular Interventions (SDCI) conference was held in La Jolla, CA. The two-day meeting focused on robotics for coronary and peripheral interventions and CHIP, or Complex High-Risk (and Indicated) Patients.